North American Pharmaceutical-Biotech Industry 2006 Capital Spending Outpaces 2005
North American Pharmaceutical-Biotech Industry 2006 Capital Spending Outpaces 2005
Attachment: North American Pharmaceutical Spending Summary Chart
For 2006, the number of projects dropped to 353, but represented a TIV of $16.8 billion. The first quarter update revealed a loss of 29 projects and a drop in TIV to $15.1 billion. - Includes North American Pharmaceutical Spending Summary Chart
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
